Hydroxychloroquine : quelle place dans le traitement de la thrombopénie auto-immune ?
Caroline Le Jeune(Hospices Civils de Lyon), J.-C. Lega(Hôpital Lyon Sud), Fiorenza Barraco(Hôpital Lyon Sud), P. Sève(Hospices Civils de Lyon), S. Khenifer(Hôpital Lyon Sud), F. Badet, A. Hot(Hospices Civils de Lyon), I. Durieu
Cited by 0
Related Papers
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
|Autoimmunity Reviews|2020|693
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
|Cells|2021|458
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309